Identifying Cancer Driver Genes Using a Neural Network Framework with Cross-attention Mechanism
- PMID: 40811289
- DOI: 10.1109/TCBBIO.2025.3588156
Identifying Cancer Driver Genes Using a Neural Network Framework with Cross-attention Mechanism
Abstract
Identifying cancer driver genes can accelerate the discovery of drug targets and the development of cancer therapies. Recent research methods improve the accuracy of identifying cancer driver genes by using deep learning framework. However, due to ignore the connection among learned features, they usually have weak feature representations that limits further improvement in the accuracy of identifying cancer driver genes. In this work, we propose a graph neural network framework combining graph convolutional network, Transformer with crossattention, and multi-layer perceptron classifier, called GTCM, to improve the accuracy of identifying cancer driver genes. Specifically, GTCM firstly uses graph convolutional network to learn gene feature representations from three different gene association networks. Secondly, to enhance the feature representations of cancer driver genes, GTCM adopts Transformer with crossattention to dynamically learn the connections between different feature sets. Finally, GTCM predicts cancer driver genes using multi-layer perceptron classifier. Ablation experiments prove that Transformer with cross-attention effectively improves the feature representations learned from graph convolutional network and further improves the identification rate. Compared with existing representative methods, GTCM exhibits excellent performance in terms of area under the receiver operating characteristic curves and area under precision-recall curves. The source codes and data are available at https://github.com/MuWang17/GTCM.
Similar articles
-
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.Clin Orthop Relat Res. 2023 Nov 1;481(11):2247-2256. doi: 10.1097/CORR.0000000000002771. Epub 2023 Aug 23. Clin Orthop Relat Res. 2023. PMID: 37615504 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Multi-view based heterogeneous graph contrastive learning for drug-target interaction prediction.J Biomed Inform. 2025 Aug;168:104852. doi: 10.1016/j.jbi.2025.104852. Epub 2025 Jun 2. J Biomed Inform. 2025. PMID: 40466979
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119. Online ahead of print. Health Technol Assess. 2025. PMID: 40580049 Free PMC article.